Unknown

Dataset Information

0

Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.


ABSTRACT:

Background

Genetic variation at a multigene cluster at chromosome 3p21.31 and the ABO blood group have been associated with the risk of developing severe COVID-19, but the mechanism remains unclear. Complement activation has been associated with COVID-19 severity.

Objective

The aim of this study was to examine whether chromosome 3p21.31 and the ABO variants are linked to the activation of the complement cascade in COVID-19 patients.

Methods

We considered 72 unrelated European hospitalized patients with genetic data and evaluation of circulating C5a and soluble terminal complement complex C5b-9 (SC5b-9). Twenty-six (36.1%) patients carried the rs11385942 G>GA variant and 44 (66.1%) non-O blood group associated with increased risk of severe COVID-19.

Results

C5a and SC5-b9 plasma levels were higher in rs11385949 GA carriers than in non-carriers (P = 0.041 and P = 0.012, respectively), while C5a levels were higher in non-O group than in O group patients (P = 0.019). The association between rs11385949 and SC5b-9 remained significant after adjustment for ABO and disease severity (P = 0.004) and further correction for C5a (P = 0.018). There was a direct relationship between upper airways viral load and SC5b-9 in carriers of the rs11385949 risk allele (P = 0.032), which was not observed in non-carriers.

Conclusions

The rs11385949 G>GA variant, tagging the chromosome 3 gene cluster variation and predisposing to severe COVID-19, is associated with enhanced complement activation, both with C5a and terminal complement complex, while non-O blood group with C5a levels. These findings provide a link between genetic susceptibility to more severe COVID-19 and complement activation.

SUBMITTER: Valenti L 

PROVIDER: S-EPMC7796659 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-06-08 | GSE175450 | GEO
| S-EPMC8712270 | biostudies-literature
2024-05-21 | GSE267021 | GEO
| PRJNA732416 | ENA
| S-BSST416 | biostudies-other
2021-06-04 | GSE175996 | GEO
| S-SCDT-EMM-2021-15227 | biostudies-other
| S-SCDT-EMM-2020-13038 | biostudies-other
| S-EPMC7878379 | biostudies-literature